 COLUMBUS, Ohio, March 22, 2021 PRNewswire -- Stirling Ultracold, an Ohio-based manufacturer and provider of the most energy efficient, sustainable ultra-low temperature ULT biorepositories has entered into a definitive agreement to merge with BioLife Solutions NASDAQ: BLFS, a leading provider of bioproduction products and services for the Gene and Cell Therapy GCT markets. Stirling Ultracold is backed by the Ohio Innovation Fund OIF, with OIF Managing Director Bill Baumel serving on the board, the Strategic Committee alongside CEO Dusty Tenney, and acting as the Seller Representative in this transaction -- OIF Principal Faith Voinovich led the reverse diligence on BioLife for Stirling. 